12 August 2024 3 8K Report

Can anyone explain this method? Especially the last statement where it says only at 1.5 to 2.5mins was the MS/MS connected to the UPLC. How is that possible, is it a feature in this specific brand?

Ivermectin was analysed on a modular UPLC system from Shi-madzu (Kyoto, Japan) containing a system controller (CBM-20A),four pumps (LC-30AD), a degasser (DGU-20A5), a column oven(CTO-20AC), and an autosampler (SIl-30ACMP), which was cou-pled to an API 5500 QTRAP tandem mass spectrometer (AB Sciex,Framingham, MA, USA).A Kinetex C8 analytical column (2.6 m, 100 A, 50 × 2.1 mm)was installed in the 55◦C tempered column oven. A filter frit (SS0.5 m 0.62 × 0.65, Ercatech AG, Bern, Switzerland) was used toprolong the lifetime of the analytical column. Mobile phase A wasan aqueous solution of 20 mM ammonium formate supplementedwith 0.1% formic acid (pH 3.5). Mobile phase B was methanol plus0.1% formic acid. The column was conditioned at 2% mobile B duringthe first 0.25 min of each analytical run. Afterwards, the mobile Bconcentration was linearly increased to 75% over 0.5 min and to 95%within 1.75 min. 95% mobile phase B was kept constant for 0.75 min.The run was terminated by reconditioning the column for 0.5 minat 2% mobile B. The flow rate was set to 0.6 ml/min and the injec-tion volume was 10 L. Ivermectin eluted after 1.9 min, therefore the UPLC system was only connected during minute 1.5 and 2.5with the mass spectrometer to avoid superfluous contamination of the system.

Similar questions and discussions